glp-1 agonist therapy Nutritional priorities to support for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society Researchers find GLP-1 medications safe
Description
About 1 in 11 adults worldwide have diabetes mellitus, 90% of whom have type 2 diabetes mellitus(T2DM) (Zheng et al., 2018)
This may help the industry win renewed tax breaks or a loosening of regulations
Recent studies suggest that glucagon receptor signaling is disrupted in NAFLD, indicating that supra-physiological glucagon receptor agonism might represent a new NAFLD treatment target
Wegovy What is Wegovy
Neurology 101:e2138e2150
Gerstein HC, Sattar N, Rosenstock J et al (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
